Abstract
High risk non-ST elevation acute coronary syndrome (HR-NSTE ACS) patients undergoing percutaneous coronary intervention (PCI), have a lower risk of bleeding with bivalirudin (BV) compared to unfractionated heparin (UFH) plus a GP IIb/IIIa inhibitor. We implemented a single center pilot protocol
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
